InsiderTrades

Form 4 for GKOS GLAUKOS Corp

Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-15 · accession 0001415889-22-012786 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-12-19 2022-12-15 GKOS Burns Thomas William COB, CEO, Dir A - Grant $0.00 +10.4K 684.7K +2% $0
D 2022-12-19 2022-12-15 GKOS Burns Thomas William COB, CEO, Dir A - Grant $0.00 +21.0K 21.0K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-12-15 A A 10,420 $0.00 684,705 D — — (F1) Represents shares of common stock underlying a portion of an award of restricted stock units previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation, Nominating and Governance Committee of the Issuer's Board of Directors (the "Compensation Committee") determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. 70% of the number of shares of common stock reported herein will vest and be delivered in January 2023, and the remaining 30% will vest and be delivered in March 2023. (F2) Includes 91,279 restricted stock units that have not yet vested or been delivered to the Reporting Person.
2 Derivative Stock Option (Right to Buy) 2022-12-15 A A 21,039 $0.00 21,039 D $55.18 · — to 2032-03-24 21,039 Common Stock (F3) Represents a portion of an option to purchase shares of common stock previously granted by the Issuer on March 24, 2022, the vesting of which was subject to the Issuer's achievement of certain pre-determined operational targets over a multi-year performance period. The Compensation Committee determined on December 15, 2022 that certain of the operational targets had been achieved. The number of shares of common stock subject to the stock option as reported herein consists of the portion of the award that was earned based upon the achievement of the operational targets. (F4) 70% of the portion of the option reported herein will vest and become exercisable in January 2023, and the remaining 30% will vest and become exercisable in March 2023.